IGM Biosciences Statistics

Total Valuation

IGM Biosciences has a market cap or net worth of $76.35 million. The enterprise value is -$31.80 million.

Market Cap	76.35M
Enterprise Value	-31.80M

Important Dates

The last earnings date was Tuesday, May 13, 2025, after market close.

Earnings Date	May 13, 2025
Ex-Dividend Date	n/a

Share Statistics

IGM Biosciences has 60.12 million shares outstanding. The number of shares has increased by 8.10% in one year.

Current Share Class	34.73M
Shares Outstanding	60.12M
Shares Change (YoY)	+8.10%
Shares Change (QoQ)	+0.52%
Owned by Insiders (%)	1.99%
Owned by Institutions (%)	10.17%
Float	11.39M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	28.79
Forward PS	4.76
PB Ratio	109.28
P/TBV Ratio	109.38
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 5.71, with a Debt / Equity ratio of 62.98.

Current Ratio	5.71
Quick Ratio	5.43
Debt / Equity	62.98
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -245.59% and return on invested capital (ROIC) is -86.87%.

Return on Equity (ROE)	-245.59%
Return on Assets (ROA)	-36.78%
Return on Invested Capital (ROIC)	-86.87%
Return on Capital Employed (ROCE)	-96.00%
Revenue Per Employee	$17,993
Profits Per Employee	-$1.33M
Employee Count	149
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -86.03% in the last 52 weeks. The beta is 0.60, so IGM Biosciences's price volatility has been lower than the market average.

Beta (5Y)	0.60
52-Week Price Change	-86.03%
50-Day Moving Average	1.22
200-Day Moving Average	6.71
Relative Strength Index (RSI)	52.82
Average Volume (20 Days)	173,642

Short Selling Information

The latest short interest is 988,761, so 1.64% of the outstanding shares have been sold short.

Short Interest	988,761
Short Previous Month	874,446
Short % of Shares Out	1.64%
Short % of Float	8.68%
Short Ratio (days to cover)	6.30

Income Statement

In the last 12 months, IGM Biosciences had revenue of $2.68 million and -$198.87 million in losses. Loss per share was -$3.27.

Revenue	2.68M
Gross Profit	-129.42M
Operating Income	-171.55M
Pretax Income	-236.33M
Net Income	-198.87M
EBITDA	-162.34M
EBIT	-171.55M
Loss Per Share	-$3.27

Full Income Statement

Balance Sheet

The company has $152.11 million in cash and $43.96 million in debt, giving a net cash position of $108.15 million or $1.80 per share.

Cash & Cash Equivalents	152.11M
Total Debt	43.96M
Net Cash	108.15M
Net Cash Per Share	$1.80
Equity (Book Value)	698,000
Book Value Per Share	0.01
Working Capital	132.84M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$143.10 million and capital expenditures -$3.40 million, giving a free cash flow of -$146.50 million.

Operating Cash Flow	-143.10M
Capital Expenditures	-3.40M
Free Cash Flow	-146.50M
FCF Per Share	-$2.44

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-6,398.81%
Pretax Margin	-7,417.79%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

IGM Biosciences does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-8.10%
Shareholder Yield	-8.10%
Earnings Yield	-260.49%
FCF Yield	-191.89%

Analyst Forecast

The average price target for IGM Biosciences is $6.14, which is 383.47% higher than the current price. The consensus rating is "Hold".

Price Target	$6.14
Price Target Difference	383.47%
Analyst Consensus	Hold
Analyst Count	8
Revenue Growth Forecast (5Y)	33.50%
EPS Growth Forecast (5Y)	-23.89%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

IGM Biosciences has an Altman Z-Score of -7.74 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-7.74
Piotroski F-Score	3